Hong Kong After the Hong Kong Exchanges and Clearing Limited’s (HKEX) 2018 move to allow pre-revenue biotech companies to raise capital in Hong Kong under its Chapter 18A mechanism, biotech listings surged with pre-clinical companies chosing to list on HKEX as a means of accessing global capital, raising around HKD 118 billion…
Korea While the Korean medical device market dropped in size in 2020 as a result of the COVID-19 pandemic, it rebounded in 2021 to reach a record breaking height of USD 7.9 billion. Local production and exports are also experiencing significant year-on-year growth rates, as the below chart shows. Made…
China The Chinese pharma market grew by eight percent from 2016 to 2018, slowed to four percent between 2018 and 2022 in part thanks to the introduction of volume-based procurement (VBP), and looks set to return to a healthier seven percent compound annual growth rate (CAGR) up to 2025 driven by…
BACK TO HOME Rare Diseases BACK TO HOME Top 10 Global Orphan Drug Companies Ranking 2017 The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants Novartis and Roche take the top two places, followed by American…
BACK TO HOME European Mid-Caps BACK TO HOME Top European Pharma Mid-Cap Ranking 2019 The European MidPharma Performance Ranking 2019 is taken from The Novasecta European Midpharma Report 2019, which examines how European mid-cap pharma companies are surviving and thriving. With scores assigned to R&D investment, commercial revenues…
Saudi Arabia The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of total sales and are a mix of local companies and MNCs Made with Visme Infographic Maker
Norway The Top 15 pharmaceutical companies in Norway ranked by sales turnover in 2019. The market is dominated by multinationals, with Novartis, Pfizer and MSD making up the top three positions. Made with Visme Infographic Maker
Hong Kong On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech companies. Nearly 2.5 years later, 20 companies have seized the opportunity to IPO under the new Chapter 18A, raising a total of over HKD 34.92 billion (USD…
Global The world’s bestselling treatments for 2019 by sales in USD billions. AbbVie’s Humira is out in front with USD 19.7 billion in sales, followed by Bristol Myers Squibb’s Eliquis, and Merck & Co. (MSD globally)’s Keytruda. Made with Visme Infographic Maker
Japan A comprehensive list of the new drugs approved by Japan’s Pharmaceutical and Medical Devices Agency (PMDA) in 2019. Made with Visme Infographic Maker
Romania Market overview with data on growth areas, key therapeutic areas, generics/originators split and more. Made with Visme Infographic Maker Romania pharma market growth and dynamics between 2018 and 2019 by segment. Made with Visme Infographic Maker
USA Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the FDA’s Center for Drug Evaluation and Research (CDER). Approvals of products such as vaccines and gene therapies by the Center for Biologics Evaluation and Research (CBER) are not included in this drug count. Made with…
See our Cookie Privacy Policy Here